Common side effects may include nausea, diarrhea, and reduced appetite
However, the inclusion of GIP in Tirzepatide provides a broader impact on blood sugar regulation compared to Semaglutide, which acts solely through the GLP-1 pathway
Tirzepatide versus semaglutide In the direct head-to-head comparison, the 1-year risk of the primary endpoint including all-cause mortality was 1.3% (95% CI 1.2% to 1.5%) for tirzepatide and 1.3% (95% CI 1.2% to 1.5%) for semaglutide, resulting in a risk difference of 0.0% (95% CI 0.2% to 0.2%) and an HR of 1.06 (95% CI 0.95 to 1.18) (Fig
Your doctor cannot disclose your tirzepatide use to anyone without your consent, except in very specific legal circumstances
What to Know About MA Plans Formularies vary: Not all MA plans have added Zepbound for OSA to their formulary Prior authorization required: Nearly all plans require PA with sleep study documentation Cost sharing varies: Plans have different tiers, copays, and coinsurance 2026 out-of-pocket limits: In-network maximum is $9,250 (down from $9,350 in 2025) [5] Open Enrollment Consideration If your current Medicare plan doesn't cover Zepbound for OSA, you may be able to switch to a plan that does during the Annual Enrollment Period (October 15 - December 7) or Medicare Advantage Open Enrollment (January 1 - March 31)
Any new or worsening symptoms after starting tirzepatide or adding new medications or supplements
